• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Medable Launches No-Code Platform for Clinical Trials

by Syed Hamza Sohail 08/15/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Medable Inc., the leading technology platform for clinical trials, today announced Medable Studio, an all-in-one application for configuring, translating, validating, and launching eCOA Plus (eCOA, eConsent, Televisit, Sensors) into clinical trials.

–  Studio is a no-code suite that simplifies the complex eCOA launch process, giving biopharmaceutical companies greater control and transparency for faster study go-live and earlier patient enrollment. Customers choose between self-service, full-service, or a combination of options, all providing increased time and cost efficiency.

Medable Studio: Revolutionizing Clinical Trial Design with Cutting-Edge Technology

Medable Studio is transforming the clinical trial design process by enabling protocol-fit study designs—previously requiring months of configuration and translation—to be created within hours. With an intuitive interface, Medable Studio empowers non-technical users to rapidly build and launch complex clinical trials, all while leveraging Medable’s cloud platform to ensure access to the latest capabilities. This technology-first solution disrupts the traditionally opaque, professional services-dependent eCOA industry by enhancing control, transparency, and speed.

Medable Studio offers a comprehensive suite of innovative functions, including:

– Point-and-Click Builder: Create assessments, instruments, and diaries quickly using features such as no-code formatting, live preview, branching rules, and globalization support for translations.

– Visual Schedule of Assessments Builder: Easily add assessments and instruments to a study schedule, configure standard visits, workflows, and notifications, as well as manage unscheduled and remote visits.

– Translation Workbench: Streamline translation processes and eliminate bottlenecks by managing all translations seamlessly. Edit only the necessary content for translation and import it back efficiently, saving time and resources.

– Content Library: Store assessments, instruments, translations, and locales in a single system, allowing for easy reuse across multiple studies.

Medable, ranked in the top 8% of software companies on the 2023 Inc. 5000, has successfully deployed its software-as-a-service platform in over 300 decentralized and hybrid clinical trials across 60 countries, serving more than one million patients and research participants globally. Customers using Medable Studio have achieved remarkable outcomes, including a 200% increase in enrollment speed and a 50% reduction in costs.
Medable Studio upends the traditional study build/test/launch process by streamlining it using intelligence and automation,” said Tim Smith, Medable Chief Technology Officer and co-founder. “With Medable Studio, timelines shift from weeks and months to just days. Customers describe Studio as a quantum leap in speed, scale, and quality, and empowers sponsors with complete visibility and control over the entire process.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Trials, Medable

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |